Arlington Trust CO LLC Neogenomics Inc Transaction History
Arlington Trust CO LLC
- $471 Million
- Q4 2024
A detailed history of Arlington Trust CO LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Arlington Trust CO LLC holds 108 shares of NEO stock, worth $1,452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108
Previous 108
-0.0%
Holding current value
$1,452
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
124MCall Options Held
698KPut Options Held
116K-
Black Rock Inc. New York, NY19.7MShares$265 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$189 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$92.7 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$88.8 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$88 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.69B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...